Oxcarbazepine in the treatment of childhood epilepsy

Pediatric Neurology

Volumn 28, Issue 1, 2003, Pages 37-41

  Serdaroglu, Gul ^a   Kurul, Semra ^b   Tutuncuoglu, Sarenur ^a   Dirik, Eray ^a   Sarioglu, Berrak ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Medical Faculty of Dokux Eylul Univ   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; OXCARBAZEPINE;

ADOLESCENT; AGGRESSIVENESS; ARTICLE; BENIGN CHILDHOOD EPILEPSY; BLOOD CELL COUNT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; ELECTROCARDIOGRAPHY; ELECTROLYTE BALANCE; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HEADACHE; HUMAN; LEUKOPENIA; LIPID BLOOD LEVEL; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; MONOTHERAPY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; SIDE EFFECT; VERTIGO; WEIGHT GAIN;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; FEMALE; HUMANS; MALE; TREATMENT OUTCOME;

EID: 0344520440     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(02)00467-8     Document Type: Article

References (18)

1. Lloyd P., Flesch G., Dieterle W. Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia. 35:(Suppl 3):1994;S10-13.
2. Wamil A.W., Schmutz M., Portet C., Feldmann K.F., McLean M.J. Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures. Eur J Pharmacol. 271:1994;301-308.
3. Stefani A., Spadoni F., Bernardi G. Voltage-activated calcium channels Targets of antiepileptic drug therapy? Epilepsia. 38:1997;959-965.
4. Beydoun A. Monotherapy trials of new antiepileptic drugs. Epilepsia. 38:(Suppl):1997;21-31.
5. Fisher R., Blum D. Clobazam, oxcarbazepine, tiagabine, topiramate and other new antiepileptic drugs. Epilepsia. 36:1995;105-114.
6. Dichter M.A., Brodie M.J. New antiepileptic drugs. N Engl J Med. 334:1996;1523-1590.
7. Commission on classification and terminology of the International League Against Epilepsy. A revised proposal for the classification of epilepsy and epileptic syndromes. Epilepsia 1989;30:268-78.
8. Van Parys J.A.P., Meinardi H. Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis. Epilepsia Res. 19:1994;79-85.
9. Wellington K., Goa K.L. Oxcarbazepine An update of its efficacy in the management of epilepsy. CNS Drugs. 15:2001;137-163.
10. Gaily E., Granström M.L., Liukkonen E. Oxcarbazepine in the treatment of early childhood epilepsy. J Child Neurol. 12:1997;496-498.
11. Dam M., Ekberg R., Loyning Y., Waltimo O., Jakobsen K. A double blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed previously untreated epilepsy. Epilepsy Res. 3:1989;70-76.
12. Beydoun A., Sachdeo R.C., Rosenfeld W.E., et al. Oxcarbazepine monotherapy for partial-onset seizures. A multicenter, double-blind, clinical trial. Neurology. 54:2000;2245-2251.
13. Sachdeo R., Beydoun A., Schachter S., et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology. 57:2001;864-871.
14. Schachter S.C., Vazquez B., Fisher R.S., et al. Oxcarbazepine. Double blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology. 52:1999;732-737.
15. Isojarvi J.I.T., Pakarinen A.J., Rautio A., Pelkonen O., Myllyla V.V. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Epilepsia. 35:1994;1217-1220.
16. Papacostas S.S. Oxcarbazepine versus carbamazepine treatment and induction of serum lipid abnormalities. J Child Neurol. 15:2000;138-140.
17. Tecoma E.S. Oxcarbazepine. Epilepsia. 40:(Suppl 5):1999;37-46.
18. Borusiak P., Merker E., Holert N., Boenigk E. Oxcarbazepine treatment of childhood epilepsy A survey of 46 children and adolescents. J Epilepsy. 11:1998;355-360.